http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RO-98727-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c69978471d06e61e6562700cc0b24102 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3469e88c0da67577f19944a61e22c094 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-21 |
filingDate | 1987-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1738bc63a346eee08974ecd66f105bb3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bc0462c3effea9048840dc92310499a |
publicationDate | 1990-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RO-98727-B1 |
titleOfInvention | MEDICINE USED IN TREATMENT OF GASTRIC AND DUODENAL ULTRAS |
abstract | The present invention relates to a drug used in the treatment of gastric and duodenal ulcers, which, in order to correct vascular perturbations involved in ulcerogenesis, consists of 1.6% nitroglycerin solution 1%, 0.8% procaine hydrochloride, 2% papaverine hydrochloride, 6% magnesium trisilicate, 6% 2% carboximethylcellulose mucilage, 8% beladon syrup, 28% mint water and up to 100% preservative solution. |
priorityDate | 1987-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.